NCT02049905 2024-06-13Phase 3 Study to Treat Patients With Soft Tissue SarcomasImmunityBio, Inc.Phase 3 Completed433 enrolled 10 charts
NCT01514188 2024-05-29Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue SarcomaImmunityBio, Inc.Phase 2 Completed126 enrolled 13 charts
NCT02570412 2015-10-22Compassionate Use of Aldoxorubicin in Sarcoma Patients ChemotherapyCytRxNo longer available